AzurRx Biopharma (AZRX) PT Lowered to $3 at Maxim Group
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy lowered the price target on AzurRx Biopharma (NASDAQ: AZRX) to $3.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
